Biotech

Latest Articles

Cassava pays $40M over supposedly deceptive Alzheimer's improve

.Cassava Sciences has consented to pay out $40 thousand to solve an investigation right into cases i...

Merck bags possibilities on Evaxion's AI-designed injection applicants

.Merck &amp Co. has actually picked up options on 2 Evaxion Biotech injection candidates, spending $...

Enanta's RSV antiviral crushes virus-like load in obstacle research study

.Enanta Pharmaceuticals has connected its breathing syncytial virus (RSV) antiviral to substantial d...

Biogen canisters SAGE-324 collaboration after important shake fail

.Biogen has actually administered the last rites to its own partnership with Sage Rehabs on SAGE-324...

AbbVie Parkinson's medication coming from $8.7 B Cerevel buyout ratings

.On the same day that some Parkinson's ailment medications are actually being actually disputed, Abb...

Arch closes $3B-plus fund to foster biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Funds Lifestyle Sciences, Arc Project Partners i...

Orion to utilize Aitia's 'digital doubles' to discover new cancer drugs

.Finnish biotech Orion has actually snooped possible in Aitia's "electronic identical twin" speciali...

Windtree's surprise med increases blood pressure in most up-to-date stage 2 gain

.While Windtree Therapies has had a hard time to expand the economic origins needed to endure, a pha...

2 cancer biotechs combine, developing global impact

.OncoC4 is taking AcroImmune-- as well as its own internal clinical production functionalities-- und...

Amgen files initial period 3 win for $400M eczema medication

.Amgen has actually discussed (PDF) the initial stage 3 data on its own $400 thousand eczema drug, c...

Biogen, UCB record period 3 lupus win after stopping working earlier test

.Biogen and UCB's depend developing into period 3 on the back of a failed research study seeks to ha...

Aptadir wishes brand-new RNA inhibitors can easily turn around complicated cancers cells

.Italian biotech Aptadir Therapies has actually released with the assurance that its own pipeline of...

Wave surfs DMD effectiveness to regulators' doors, sending out stock up

.Wave Lifestyle Sciences has actually met its goal in a Duchenne muscular dystrophy (DMD) research s...

Sanofi picks brand new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, occup...

Achilles droplets tissue therapy program, bandages for layoffs after missing out on 'office viability' objectives

.Achilles Rehabs has actually shreded its tactic. The British biotech is quiting working on its clin...

Aligos trumpets period 2 MASH win, lowering liver excess fat as much as 46%

.Aligos Therapeutics is heralding a midstage win in metabolic-dysfunction connected steatohepatitis ...

Basilea credit ratings $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work cultivating brand-new antifungals has actually acquired a substantial ...

Capricor markets Europe legal rights to late-stage DMD treatment for $35M

.Possessing currently scooped up the U.S. liberties to Capricor Therapeutics' late-stage Duchenne mu...

FDA junks adcomm for Applied's unusual health condition medication

.After pushing back the selection date for Applied Therapies' metabolic condition drug govorestat, t...

Novo inks $600M NanoVation package to examine hereditary medications ex-liver

.Novo Nordisk is actually proceeding its press in to hereditary medications, agreeing to compensate ...